HAYMINE

Posology Adults, elderly and children over 12 years of age One or two tablets daily. One tablet should be taken in the morning on rising and a further tablet may be taken at night if required. Paediatric population Not recommended in children under 12 years of age.

Method of administration Oral administration.

Although the combination of ephedrine with the anti-histamine chlorphenamine is intended to reduce side-effects, slight drowsiness may occur. Side effects of ephedrine are rare at the low dose employed in this preparation, however in particularly susceptible patients, effects such as giddiness, palpitations and muscular weakness may be experienced transiently.

Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Haymine Tablets should be swallowed whole and not sucked or chewed. Do not exceed the stated dose. Asthmatics should consult their doctor before using this product. May cause drowsiness, if affected do not drive or operate machinery. Avoid alcoholic drink.

Excipients This medicine contains hydrogenated castor oil which may cause stomach upset and diarrhea. This medicine contains methyl parahydroxybenzoate (E218), ethyl parahydroxybenzoate (E214), propyl parahydroxybenzoate (E216), butyl parahydroxybenzoate and isobutyl parahydroxybenzoate which may cause allergic reactions (possibly delayed).

1. Use in patients with coronary thrombosis, hypertension, thyrotoxicosis and those on treatment with monoamine oxidase inhibitors.